Advertisement
Advertisement
ARDT
Ardent Health, Inc.
10.11
USDSponsored
+0.21
+2.12%
May 08, 16:00 UTC -4
Closed
After-Market
10.12
+0.01
+0.05%
ARDT Earnings Reports
Positive Surprise Ratio
ARDT beat 6 of 8 last estimates.
75%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.70B
/$0.33
Implied change from Q1 26 (Revenue/ EPS)
+5.96%
/+17.86%
Implied change from Q2 25 (Revenue/ EPS)
+3.16%
/-36.54%
Ardent Health, Inc. earnings per share and revenue
On May 05, 2026, ARDT reported earnings of 0.28 USD per share (EPS) for Q1 26, beating the estimate of 0.18 USD, resulting in a 48.62% surprise. Revenue reached 1.60 billion, compared to an expected 1.61 billion, with a -0.75% difference. The market reacted with a -7.50% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.33 USD, with revenue projected to reach 1.70 billion USD, implying an increase of 17.86% EPS, and increase of 5.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
FAQ
What were Ardent Health, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Ardent Health, Inc. reported EPS of $0.28, beating estimates by 48.62%, and revenue of $1.60B, -0.75% below expectations.
How did the market react to Ardent Health, Inc.'s Q1 2026 earnings?
The stock price moved down -7.5%, changed from $10.13 before the earnings release to $9.37 the day after.
When is Ardent Health, Inc. expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Ardent Health, Inc.'s next earnings report?
Based on --
analysts, Ardent Health, Inc. is expected to report EPS of $0.33 and revenue of $1.70B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement